ArticleInternational urology and nephrology2026
Segmental ureterectomy versus radical nephroureterectomy for middle and distal ureteral tumors associated with hydronephrosis: a comparative analysis of oncological outcomes and postoperative renal function.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRadical nephroureterectomy (RNU) is the standard for high-risk upper tract urothelial carcinoma but causes inevitable renal functional decline. We evaluated the oncological outcomes and renal preservation of segmental ureterectomy (SU) versus RNU specifically for middle and distal ureteral tumors associated with hydronephrosis.
methodsWe retrospectively reviewed 139 patients (55 SU, 84 RNU) with middle or distal ureteral tumors and hydronephrosis treated between 2014 and 2024. Endpoints included overall survival (OS), cancer-specific survival (CSS), recurrence-free survival (RFS), and intravesical recurrence-free survival (IVRFS). Perioperative renal function was evaluated using estimated glomerular filtration rate (eGFR).
resultsDuring a median follow-up of 40.6 months, baseline characteristics were well balanced between the SU and RNU groups after overlap weighting. Despite a high proportion of high-risk disease (77.9% ≥ T2, 59.2% high-grade), no significant differences existed between SU and RNU in OS (P = 0.969), CSS (P = 0.840), RFS (P = 0.957), or IVRFS (P = 0.941). Weighted Cox proportional hazards confirmed survival was dictated by tumor characteristics (stage, grade, length, lymph node involvement, surgical margins, vascular invasion and tumor necrosis), not surgical modality. Longitudinal mixed-effects analysis demonstrated that SU was associated with significantly higher postoperative eGFR compared with RNU across all follow-up intervals (P < 0.001).
conclusionsFor middle and distal ureteral tumors presenting with hydronephrosis, no statistically significant differences in long-term oncological outcomes were observed between SU and RNU within the current cohort. SU demonstrated higher postoperative eGFR values, suggesting a potential nephron-sparing advantage in carefully selected patients.
Indexed as
Identifiers
42749990What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.